New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XHEvsGNOMETF Comparison

ETF 1
XHE

SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0.31%
Full XHE fund page
VS
ETF 2
GNOM

Global X Genomics & Biotechnology ETF - USD

This fund is part of
BioTech & Genomics
-0.12%
Full GNOM fund page

SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Global X Genomics & Biotechnology ETF - USD (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. XHE is down -6.79% year-to-date (YTD) with -$4M in YTD flows. GNOM performs better with -0.99% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of XHE and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs GNOM performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

Feb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
GNOM
-4.63%-2.35%
-8.38%-3.29%
-6.79%-0.99%
-1.88%+29.80%
-7.27%-6.02%
-31.62%-51.80%
Flows
XHE
GNOM
--
-$7M-$4M
-$4M-$2M
-$44M-$19M
-$295M-$115M
-$430M+$11M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
GNOM
+18.94%+23.45%
+23.53%+30.08%
+21.07%+28.53%
+24.17%+33.47%
Max drawdown
XHE
GNOM
-12.38%-10.89%
-14.34%-22.14%
-32.63%-46.50%
-49.90%-72.17%
Max drawdown duration
XHE
GNOM
62d48d
241d113d
1053d1031d
1651d1714d
Trading data

Create an account to view trading data

Join for free
XHE
GNOM
Last sale
3/12/2026 at 1:30 PM
$79.80
$43.93
Previous close
03/11/2026
$82.04
$45.00
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
XHE
GNOM
Last price
$79.80
$43.93
1D performance
-2.73%
-2.38%
AuM$139.64 M$49.36 M
E/R0.35%0.5%
Characteristics
XHE
GNOM
Management strategyPassivePassive
ProviderSPDRGlobal X
BenchmarkS&P Health Care Equipment Select Industry IndexSolactive Genomics Index
N° of holdings6146
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011April 5, 2019
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
92.71%
Other
7.29%
GNOM
USA
87.04%
Other
12.96%

Sectors

XHE
Health Care
93.87%
Other
6.13%
GNOM
Health Care
87.95%
Other
12.05%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

30.47%
GNOM

Total weight of top 15 holdings out of 15

63.95%

Top 15 holdings

Data as of January 31, 2026
XHE
NEOGEN
2.63%
INTEGER HOLDINGS
2.17%
PENUMBRA
2.12%
UFP TECHNOLOGY
2.11%
AXOGEN
2.09%
OMNICELL
1.98%
LANTHEUS HOLDINGS
1.98%
BAXTER INTL
1.98%
GLAUKOS
1.97%
DEXCOM
1.94%
DENTSPLY SIRONA
1.92%
BUTTERFLY NETWORK INC
1.92%
ENVISTA HOLDINGS CORP
1.91%
STRYKER
1.88%
GLOBUS MEDICAL
1.86%
GNOM
MODERNA INC
6.79%
ARROWHEAD PHARMACEUTICALS INC
6.14%
US74006W2070
5.75%
ILLUMINA
5.64%
GUARDANT HEALTH INC
5.47%
NATERA
4.30%
VERTEX PHARMACEUTICALS
4.08%
BIONTECH SE ADR
4.04%
BIOMARIN PHARMACEUTICAL
3.93%
AVIDITY BIOSCIENCES
3.73%
BIO-TECHNE CORP
3.69%
CRISPR THERAPEUTICS
3.05%
ALNYLAM PHARMACEUTICALS
2.58%
VERACYTE INC/D
2.50%
BRISTOL-MYERS SQUIBB
2.28%
Frequently asked questions about XHE and GNOM

How have the XHE and GNOM ETFs performed in 2026?

As of March 11, 2026, XHE is down -6.79% year-to-date (YTD), while GNOM has lost -0.99%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or GNOM?

Year-to-date, the XHE ETF saw -$4M in flows, compared to -$2M for GNOM.

Which ETF is more volatile: XHE or GNOM?

Over the past year, XHE had a volatility of 23.53%, while GNOM experienced 30.08%.

Which ETF is bigger: XHE or GNOM?

As of March 11, 2026, XHE holds $139.64 M in assets under management (AUM), while GNOM manages $49.36 M.

What sectors do the XHE and GNOM ETFs invest in?

XHE leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the XHE ETF and GNOM ETF?

XHE top holdings include NEOGEN, INTEGER HOLDINGS and PENUMBRA. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

Which ETF is more diversified: XHE or GNOM?

XHE holds 64 securities with 30.47% of its assets in the top 15. GNOM has 48 securities and a top 15 weight of 63.95%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast